(a) H292-Gef versus H292 up-regulated |
ILMN_1795325 |
ACTG2 |
19.58 |
Actin, gamma 2, smooth muscle, enteric |
NM_001615 |
ILMN_1801216 |
S100P |
8.62 |
S100 calcium binding protein P |
NM_005980 |
ILMN_1729801 |
S100A8 |
6.80 |
S100 calcium binding protein A8 |
NM_002964 |
ILMN_2093343 |
PLAC8 |
6.13 |
Placenta-specific 8 |
NM_016619 |
ILMN_2112128 |
MAPK4 |
5.83 |
Mitogen-activated protein kinase 4 |
NM_002747 |
ILMN_1653026 |
PLAC8 |
5.15 |
Placenta-specific 8 |
NM_016619 |
ILMN_2149164 |
SFRP1 |
4.54 |
Secreted frizzled-related protein 1 |
NM_003012 |
ILMN_1689329 |
SCD |
4.37 |
Stearoyl-CoA desaturase (delta-9-desaturase) |
NM_005063 |
ILMN_1715508 |
NNMT |
4.33 |
Nicotinamide N-methyltransferase |
NM_006169 |
ILMN_1750974 |
S100A9 |
3.87 |
S100 calcium binding protein A9 (calgranulin B) |
NM_002965 |
ILMN_1723035 |
OLR1 |
3.79 |
Oxidized low density lipoprotein (lectin-like) receptor 1 |
NM_002543 |
(b) H292-Gef versus H292 down-regulated |
ILMN_2150851 |
SERPINB2 |
−21.64 |
Serpin peptidase inhibitor, clade B (ovalbumin), member 2 |
NM_002575 |
ILMN_2212878 |
ESM1 |
−6.97 |
Endothelial cell-specific molecule 1 |
NM_007036 |
ILMN_1688892 |
LAMA3 |
−6.45 |
Laminin, alpha 3 |
NM_198129 |
ILMN_2406035 |
LAMA3 |
−6.16 |
Laminin, alpha 3 |
NM_198129 |
ILMN_2219002 |
KRT6A |
−5.62 |
Keratin 6A, type II |
NM_005554 |
ILMN_2150856 |
SERPINB2 |
−5.57 |
Serpin peptidase inhibitor, clade B (ovalbumin), member 2 |
NM_002575 |
ILMN_1651365 |
ZBED2 |
−5.45 |
Zinc finger, BED-type containing 2 |
NM_024508 |
ILMN_1707727 |
ANGPTL4 |
−4.82 |
Angiopoietin-like 4 |
NM_139314 |
ILMN_1653824 |
LAMC2 |
−4.32 |
Laminin, gamma 2 |
NM_005562 |
ILMN_1701424 |
LAMC2 |
−4.17 |
Laminin, gamma 2 |
NM_005562 |
ILMN_1798181 |
IRF7 |
−4.15 |
Interferon regulatory factor 7 |
NM_004029 |
ILMN_1695590 |
ADRB2 |
−4.08 |
Adrenoceptor beta 2, surface |
NM_000024 |
ILMN_1674620 |
SGCE |
−3.98 |
Sarcoglycan, epsilon |
NM_001099400 |